206 related articles for article (PubMed ID: 8104681)
1. Expression of c-erbB-2 protein and epidermal growth receptor in endometrial carcinomas. Correlation with clinicopathologic and sex steroid receptor status.
Wang D; Konishi I; Koshiyama M; Mandai M; Nanbu Y; Ishikawa Y; Mori T; Fujii S
Cancer; 1993 Nov; 72(9):2628-37. PubMed ID: 8104681
[TBL] [Abstract][Full Text] [Related]
2. Expression of epidermal growth factor family proteins and epidermal growth factor receptor in human endometrium.
Niikura H; Sasano H; Kaga K; Sato S; Yajima A
Hum Pathol; 1996 Mar; 27(3):282-9. PubMed ID: 8600044
[TBL] [Abstract][Full Text] [Related]
3. The relationship of cerb B 2 expression with estrogen receptor and progesterone receptor and prognostic parameters in endometrial carcinomas.
Gul AE; Keser SH; Barisik NO; Kandemir NO; Cakir C; Sensu S; Karadayi N
Diagn Pathol; 2010 Feb; 5():13. PubMed ID: 20167054
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical analysis of p53 protein over-expression in endometrial carcinomas: inverse correlation with sex steroid receptor status.
Koshiyama M; Konishi I; Wang DP; Mandai M; Komatsu T; Yamamoto S; Nanbu K; Naito MF; Mori T
Virchows Arch A Pathol Anat Histopathol; 1993; 423(4):265-71. PubMed ID: 8236823
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical comparison of uterine papillary serous and papillary endometrioid carcinoma: clues to pathogenesis.
Demopoulos RI; Mesia AF; Mittal K; Vamvakas E
Int J Gynecol Pathol; 1999 Jul; 18(3):233-7. PubMed ID: 12092593
[TBL] [Abstract][Full Text] [Related]
6. Expression of EGFR, HER-2/neu, P53, and PCNA in endometrioid, serous papillary, and clear cell endometrial adenocarcinomas.
Khalifa MA; Mannel RS; Haraway SD; Walker J; Min KW
Gynecol Oncol; 1994 Apr; 53(1):84-92. PubMed ID: 7909788
[TBL] [Abstract][Full Text] [Related]
7. Comparative immunohistochemical study of endometrioid and serous papillary carcinoma of endometrium.
Halperin R; Zehavi S; Habler L; Hadas E; Bukovsky I; Schneider D
Eur J Gynaecol Oncol; 2001; 22(2):122-6. PubMed ID: 11446475
[TBL] [Abstract][Full Text] [Related]
8. [Correlation between receptor status and results of treatment in endometrial carcinoma].
Baĭnazarova AA; Iskakova ZhK
Vopr Onkol; 2006; 52(6):654-8. PubMed ID: 17338243
[TBL] [Abstract][Full Text] [Related]
9. Cell proliferation-associated proteins in endometrial carcinomas, including papillary serous and endometrioid subtypes.
Kallakury BV; Ambros RA; Hayner-Buchan AM; Sheehan CE; Malfetano JH; Ross JS
Int J Gynecol Pathol; 1998 Oct; 17(4):320-6. PubMed ID: 9785132
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical localization of c-erbB-2 protein and epidermal growth factor receptor in normal surface epithelium, surface inclusion cysts, and common epithelial tumours of the ovary.
Wang DP; Konishi I; Koshiyama M; Nanbu Y; Iwai T; Nonogaki H; Mori T; Fujii S
Virchows Arch A Pathol Anat Histopathol; 1992; 421(5):393-400. PubMed ID: 1360720
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of epidermal growth factor receptor expression in endometrioid endometrial carcinoma.
Niikura H; Sasano H; Matsunaga G; Watanabe K; Ito K; Sato S; Yajima A
Hum Pathol; 1995 Aug; 26(8):892-6. PubMed ID: 7635451
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical profile of endometrial adenocarcinoma: a study of 61 cases and review of the literature.
Kounelis S; Kapranos N; Kouri E; Coppola D; Papadaki H; Jones MW
Mod Pathol; 2000 Apr; 13(4):379-88. PubMed ID: 10786803
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of progesterone receptor immunohistochemistry in endometrial carcinoma.
Fukuda K; Mori M; Uchiyama M; Iwai K; Iwasaka T; Sugimori H
Gynecol Oncol; 1998 Jun; 69(3):220-5. PubMed ID: 9648591
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical expression of PTEN in normal, hyperplastic and malignant endometrium and its correlation with hormone receptors, bcl-2, bax, and apoptotic index.
Kapucuoglu N; Aktepe F; Kaya H; Bircan S; Karahan N; Ciriş M
Pathol Res Pract; 2007; 203(3):153-62. PubMed ID: 17317031
[TBL] [Abstract][Full Text] [Related]
15. Expression of hPEBP4 negatively correlates with estrogen and progesterone receptors in endometrial carcinoma.
Guo T; Li B; Gu C
J BUON; 2013; 18(2):465-70. PubMed ID: 23818363
[TBL] [Abstract][Full Text] [Related]
16. p53 protein and c-erbB-2 protein (p185) expression in endometrial adenocarcinoma of endometrioid type. An immunohistochemical examination on paraffin sections.
Nielsen AL; Nyholm HC
Am J Clin Pathol; 1994 Jul; 102(1):76-9. PubMed ID: 7913577
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical study of HER-2/neu, epidermal growth factor receptor, and steroid receptor expression in normal and malignant endometrium.
Bigsby RM; Li AX; Bomalaski J; Stehman FB; Look KY; Sutton GP
Obstet Gynecol; 1992 Jan; 79(1):95-100. PubMed ID: 1345772
[TBL] [Abstract][Full Text] [Related]
18. Expression of metastasis-related nm23-H1 and nm23-H2 genes in ovarian carcinomas: correlation with clinicopathology, EGFR, c-erbB-2, and c-erbB-3 genes, and sex steroid receptor expression.
Mandai M; Konishi I; Koshiyama M; Mori T; Arao S; Tashiro H; Okamura H; Nomura H; Hiai H; Fukumoto M
Cancer Res; 1994 Apr; 54(7):1825-30. PubMed ID: 7907945
[TBL] [Abstract][Full Text] [Related]
19. Significance of epidermal growth factor receptor expression in primary human endometrial cancer.
Scambia G; Benedetti Panici P; Ferrandina G; Battaglia F; Distefano M; D'Andrea G; De Vincenzo R; Maneschi F; Ranelletti FO; Mancuso S
Int J Cancer; 1994 Jan; 56(1):26-30. PubMed ID: 8262674
[TBL] [Abstract][Full Text] [Related]
20. p53 and c-erbB-2 protein expression in breast carcinomas. An immunohistochemical study including correlations with receptor status, proliferation markers, and clinical stage in human breast cancer.
Barbareschi M; Leonardi E; Mauri FA; Serio G; Dalla Palma P
Am J Clin Pathol; 1992 Oct; 98(4):408-18. PubMed ID: 1357956
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]